Blood vessels could predict how prostate cancer would behaveNovember 4th, 2009 - 2:28 pm ICT by ANI
Washington, Nov 4 (ANI): Blood vessels in prostate cancer could act as predictor of how it would behave, say researchers at The Ohio State University and the Harvard School of Public Health.
The study of 572 men with localized prostate cancer indicates that aggressive or lethal prostate cancers tend to have blood vessels that are small, irregular and primitive in cross-section.
On the other hand, slow-growing or indolent tumours have blood vessels that look more normal.
“It’s as if aggressive prostate cancers are growing faster and their blood vessels never fully mature,” said study leader Dr. Steven Clinton.
“Prostate cancer is very heterogeneous, and we need better tools to predict whether a patient has a prostate cancer that is aggressive, fairly average or indolent in its behavior so that we can better define a course of treatment - surgery, chemotherapy, radiotherapy, hormonal therapy, or potentially new drugs that target blood vessels - that is specific for each person’s type of cancer.
“Similarly, if we can better determine at the time of biopsy or prostatectomy who is going to relapse, we can start treatment earlier, when the chance for a cure may be better,” added Clinton.
The study analysed tumour samples and clinical outcome data from men participating in the Health Professionals Follow-Up Study, which involves 51,529 male North American dentists, optometrists, podiatrists, pharmacists and veterinarians.
After an average follow-up of 10 years, 44 of the 572 men had developed metastatic cancer or died of their cancer.
Men whose tumours had smaller vessel diameters were six times more likely to have aggressive tumours and die of their disease, and those with the most irregularly shaped vessels were 17 times more likely to develop lethal prostate cancer.
The findings were published in the Journal of Clinical Oncology. (ANI)
- Molecular predictor of metastatic prostate cancer identified - Feb 03, 2011
- Potent anticancer drug isolated from weed - Jul 10, 2012
- Statins can cut prostate cancer risk - Oct 02, 2011
- New method detects aggressive prostate cancer - Aug 09, 2012
- New ultrasound technology can accurately spot prostate cancer tumours - Dec 09, 2010
- New marker to detect prostate cancer identified - Mar 26, 2009
- Scientists find new way to 'starve' cancer cells - Apr 05, 2011
- Genomic analysis of prostate cancer unveiled - Jun 26, 2010
- Super vaccine could knock out 70 percent of cancers - Dec 13, 2011
- Exercise 'cuts death risk for men with prostate cancer' - Jan 06, 2011
- Genes linked to aggressive breast cancer identified - Aug 17, 2010
- 'Watchful waiting' often best strategy for low-risk prostate cancer - Jun 19, 2010
- Surgery effective for aggressive prostate cancer patients - Sep 28, 2010
- Hidden prostate cancer tumours evade treatment: study - Oct 09, 2009
- New test accurately detects aggressive prostate cancer - Apr 07, 2011
Tags: better tools, blood vessels, clinical outcome, diameters, dr steven, harvard school of public health, hormonal therapy, new drugs, ohio state university, outcome data, prostate cancer, prostate cancers, prostatectomy, s type, school of public health, steven clinton, study leader, target, tumours, type of cancer